Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness-Reference-Cited by-同舟云学术

Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness

Published:2012-03-31 Issue:4 Volume:4 Page:207-220
ISSN:1759-4685
Container-title:Journal of Molecular Cell Biology
language:en
Short-container-title:

Author:

Puissant Alexandre,Dufies Maeva,Fenouille Nina,Ben Sahra Issam,Jacquel Arnaud,Robert Guillaume,Cluzeau Thomas,Deckert Marcel,Tichet Mélanie,Chéli Yann,Cassuto Jill-Patrice,Raynaud Sophie,Legros Laurence,Pasquet Jean-Max,Mahon François-Xavier,Luciano Frédéric,Auberger Patrick

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/jmcb/article-pdf/4/4/207/16836630/mjs010.pdf

Reference43 articles.

1. Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer;Ahmed;Curr. Cancer Drug Targets,2010

2. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc. Natl Acad. Sci. USA,2003

3. A crucial role in cell spreading for the interaction of Abl PxxP motifs with Crk and Nck adaptors;Antoku;J. Cell Sci.,2008

4. Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors;Bhatia;Blood,1998

5. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors;Bhatia;Leukemia,1998

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular signature of BCR::ABL and BCR::ABL in a Drosophila melanogaster chronic myeloid leukemia model;iScience;2024-04

2. Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line;Advances in Medical Sciences;2023-09

3. EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells;International Journal of Hematology;2022-10-25

4. Verbascoside potentiates the effect of tyrosine kinase inhibitors on the induction of apoptosis and oxidative stress via the Abl-mediated MAPK signalling pathway in chronic myeloid leukaemia;Experimental and Therapeutic Medicine;2022-06-14

5. CD44: a potential therapeutic target in chronic myeloid leukemia;PHARMAZIE;2021